Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $26,421 - $28,873
-183 Reduced 11.79%
1,369 $200,000
Q1 2024

Apr 29, 2024

SELL
$155.22 - $162.74 $126,969 - $133,121
-818 Reduced 34.51%
1,552 $246,000
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $7,571 - $8,261
52 Added 2.24%
2,370 $371,000
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $6,074 - $6,804
-39 Reduced 1.65%
2,318 $361,000
Q2 2023

Aug 04, 2023

BUY
$154.35 - $166.11 $60,350 - $64,949
391 Added 19.89%
2,357 $390,000
Q1 2023

May 01, 2023

SELL
$151.05 - $180.26 $13,745 - $16,403
-91 Reduced 4.42%
1,966 $305,000
Q4 2022

Jan 31, 2023

SELL
$160.2 - $179.79 $10,413 - $11,686
-65 Reduced 3.06%
2,057 $363,000
Q3 2022

Nov 08, 2022

BUY
$161.33 - $179.52 $13,713 - $15,259
85 Added 4.17%
2,122 $347,000
Q2 2022

Aug 09, 2022

BUY
$168.19 - $186.01 $342,603 - $378,902
2,037 New
2,037 $362,000
Q1 2022

May 09, 2022

SELL
$158.14 - $179.59 $190,874 - $216,765
-1,207 Closed
0 $0
Q4 2021

Jan 27, 2022

BUY
$155.93 - $173.01 $188,207 - $208,823
1,207 New
1,207 $206,000
Q3 2021

Nov 05, 2021

SELL
$161.5 - $179.47 $219,478 - $243,899
-1,359 Closed
0 $0
Q2 2021

Aug 04, 2021

BUY
$159.48 - $171.07 $12,439 - $13,343
78 Added 6.09%
1,359 $223,000
Q2 2021

Aug 04, 2021

SELL
$159.48 - $171.07 $12,439 - $13,343
-78 Reduced 5.74%
1,281 $211,000
Q1 2021

Apr 29, 2021

SELL
$153.07 - $170.48 $5,816 - $6,478
-38 Reduced 2.72%
1,359 $223,000
Q4 2020

Jan 28, 2021

BUY
$137.11 - $157.38 $191,542 - $219,859
1,397 New
1,397 $220,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Seascape Capital Management Portfolio

Follow Seascape Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seascape Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Seascape Capital Management with notifications on news.